ENOV
Price
$31.54
Change
+$0.48 (+1.55%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
1.78B
15 days until earnings call
Intraday Buy/Sell Signals
IART
Price
$14.40
Change
+$0.78 (+5.73%)
Updated
Oct 14 closing price
Capitalization
1.12B
14 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

ENOV vs IART

Header iconENOV vs IART Comparison
Open Charts ENOV vs IARTBanner chart's image
Enovis
Price$31.54
Change+$0.48 (+1.55%)
Volume$431
Capitalization1.78B
Integra LifeSciences Holdings
Price$14.40
Change+$0.78 (+5.73%)
Volume$826.89K
Capitalization1.12B
ENOV vs IART Comparison Chart in %
ENOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IART
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENOV vs. IART commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENOV is a Hold and IART is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (ENOV: $31.06 vs. IART: $14.40)
Brand notoriety: ENOV and IART are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ENOV: 101% vs. IART: 72%
Market capitalization -- ENOV: $1.78B vs. IART: $1.12B
ENOV [@Medical/Nursing Services] is valued at $1.78B. IART’s [@Medical/Nursing Services] market capitalization is $1.12B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.95B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENOV’s FA Score shows that 0 FA rating(s) are green whileIART’s FA Score has 1 green FA rating(s).

  • ENOV’s FA Score: 0 green, 5 red.
  • IART’s FA Score: 1 green, 4 red.
According to our system of comparison, IART is a better buy in the long-term than ENOV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENOV’s TA Score shows that 4 TA indicator(s) are bullish while IART’s TA Score has 5 bullish TA indicator(s).

  • ENOV’s TA Score: 4 bullish, 3 bearish.
  • IART’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ENOV is a better buy in the short-term than IART.

Price Growth

ENOV (@Medical/Nursing Services) experienced а +2.41% price change this week, while IART (@Medical/Nursing Services) price change was -0.21% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.96%. For the same industry, the average monthly price growth was +4.23%, and the average quarterly price growth was +21.28%.

Reported Earning Dates

ENOV is expected to report earnings on Oct 30, 2025.

IART is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Medical/Nursing Services (+1.96% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENOV($1.78B) has a higher market cap than IART($1.12B). ENOV YTD gains are higher at: -29.216 vs. IART (-36.508). IART has higher annual earnings (EBITDA): -332.17M vs. ENOV (-472.1M). IART has more cash in the bank: 254M vs. ENOV (44.1M). ENOV has less debt than IART: ENOV (1.47B) vs IART (2.01B). ENOV has higher revenues than IART: ENOV (2.19B) vs IART (1.62B).
ENOVIARTENOV / IART
Capitalization1.78B1.12B158%
EBITDA-472.1M-332.17M142%
Gain YTD-29.216-36.50880%
P/E RatioN/A66.48-
Revenue2.19B1.62B135%
Total Cash44.1M254M17%
Total Debt1.47B2.01B73%
FUNDAMENTALS RATINGS
ENOV vs IART: Fundamental Ratings
ENOV
IART
OUTLOOK RATING
1..100
109
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
80
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
8163
P/E GROWTH RATING
1..100
988
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENOV's Valuation (79) in the Industrial Machinery industry is in the same range as IART (80) in the Medical Specialties industry. This means that ENOV’s stock grew similarly to IART’s over the last 12 months.

ENOV's Profit vs Risk Rating (100) in the Industrial Machinery industry is in the same range as IART (100) in the Medical Specialties industry. This means that ENOV’s stock grew similarly to IART’s over the last 12 months.

ENOV's SMR Rating (97) in the Industrial Machinery industry is in the same range as IART (97) in the Medical Specialties industry. This means that ENOV’s stock grew similarly to IART’s over the last 12 months.

IART's Price Growth Rating (63) in the Medical Specialties industry is in the same range as ENOV (81) in the Industrial Machinery industry. This means that IART’s stock grew similarly to ENOV’s over the last 12 months.

IART's P/E Growth Rating (8) in the Medical Specialties industry is significantly better than the same rating for ENOV (98) in the Industrial Machinery industry. This means that IART’s stock grew significantly faster than ENOV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENOVIART
RSI
ODDS (%)
N/A
Bearish Trend 8 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 8 days ago
61%
Bearish Trend 8 days ago
82%
Momentum
ODDS (%)
Bullish Trend 8 days ago
58%
Bullish Trend 8 days ago
62%
MACD
ODDS (%)
Bearish Trend 8 days ago
72%
Bullish Trend 8 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
66%
Bullish Trend 8 days ago
61%
TrendMonth
ODDS (%)
Bullish Trend 8 days ago
64%
Bearish Trend 8 days ago
75%
Advances
ODDS (%)
Bullish Trend 13 days ago
62%
Bullish Trend 15 days ago
60%
Declines
ODDS (%)
Bearish Trend 9 days ago
74%
Bearish Trend 9 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 8 days ago
74%
Bullish Trend 8 days ago
66%
Aroon
ODDS (%)
Bullish Trend 8 days ago
48%
Bearish Trend 8 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
ENOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IART
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CAMZX18.060.24
+1.35%
Cambiar Small Cap Instl
GSCYX18.530.17
+0.93%
GuideStone Funds Small Cap Equity Instl
JERIX12.220.10
+0.83%
Janus Henderson Global Real Estate I
SIDVX13.200.03
+0.23%
Hartford Schroders Intl Multi-Cp Val A
AGWUX68.20-0.63
-0.92%
American Century Growth R5

ENOV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with CNMD. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then CNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENOV
1D Price
Change %
ENOV100%
+4.47%
CNMD - ENOV
62%
Loosely correlated
+2.60%
IART - ENOV
56%
Loosely correlated
+5.73%
ITGR - ENOV
56%
Loosely correlated
+1.83%
NPO - ENOV
51%
Loosely correlated
+2.68%
DOV - ENOV
50%
Loosely correlated
+0.86%
More

IART and

Correlation & Price change

A.I.dvisor indicates that over the last year, IART has been loosely correlated with ENOV. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if IART jumps, then ENOV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IART
1D Price
Change %
IART100%
+5.73%
ENOV - IART
56%
Loosely correlated
+4.47%
ZBH - IART
52%
Loosely correlated
+3.45%
CNMD - IART
51%
Loosely correlated
+2.60%
ITGR - IART
50%
Loosely correlated
+1.83%
AZTA - IART
43%
Loosely correlated
+0.26%
More